Company profile: Allphase Clinical Research
1.1 - Company Overview
Company description
- Provider of full-service Contract Research Organization (CRO) services, delivering high-quality clinical development management and strategy services for companies with products from early-stage through post-market approval.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Allphase Clinical Research
Eximia Research
HQ: United States
Website
- Description: Provider of multi-therapeutic clinical research site network services for biotech companies, conducting Phase I–IV clinical trials across therapeutic and diagnostic indications. Offers patient recruitment and engagement (including underrepresented populations), feasibility studies with investigator feedback, rapid site start-up and feasibility, regulatory and start-up support (contract and budget management), and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eximia Research company profile →
Summit Biosciences
HQ: United States
Website
- Description: Provider of specialty pharmaceutical development, manufacturing and commercialization of generic and innovative nasal spray drug products, also offering contract development and manufacturing services to partners and clients for a wide variety of nasally delivered products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Summit Biosciences company profile →
ImmunXperts
HQ: Belgium
Website
- Description: Provider of in vitro immunology services with a strong focus on immunogenicity and immuno-oncology, helping biopharma companies select their best lead candidates by assessing immune responses in donors and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunXperts company profile →
Lindus Health
HQ: United Kingdom
Website
- Description: Provider of end-to-end clinical trial services for the life sciences sector, covering ethics/IRB submissions, trial monitoring, data management, biostatistics, regulatory and payor affairs; AI-assisted trial design; direct patient recruitment; a clinical software platform (EDC, eSource, CTMS); CDISC SDTM data delivery; site and feasibility capabilities; and patient concierge support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindus Health company profile →
Syntactx
HQ: United States
Website
- Description: Provider of global clinical research services specializing in complex clinical trials, offering consulting across all phases, biostatistics and statistical programming, clinical evidence and post-market studies, clinical trial safety with in-house medical monitors and MeDRA coders, data management and EDC, and field clinical engineering staffing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syntactx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Allphase Clinical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Allphase Clinical Research
2.2 - Growth funds investing in similar companies to Allphase Clinical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Allphase Clinical Research
4.2 - Public trading comparable groups for Allphase Clinical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →